logo
logo
RMD stock ticker logo

ResMed Inc.

NYSE•RMD
CEO: Mr. Michael J. Farrell BE, MBA, SM
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Listing Date: 1995-06-02
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Contact Information
9001 Spectrum Center Boulevard, San Diego, CA, 92123, United States
858-836-5000
www.resmed.com
Market Cap
$36.07B
P/E (TTM)
24.4
35.7
Dividend Yield
0.9%
52W High
$293.81
52W Low
$199.92
52W Range
50%
Rank16Top 3.7%
6.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q2 2026 Data

Revenue

$1.42B+10.98%
4-Quarter Trend

EPS

$2.69-201.28%
4-Quarter Trend

FCF

$311.21M+7.41%
4-Quarter Trend

2026 Q2 Earnings Highlights

Key Highlights

Revenue Growth Strong Net revenue $1.42B, increasing 11% over prior period; 9% growth constant currency for the quarter.
Gross Margin Expansion Noted Gross margin reached 61.8%, up 320 basis points from 58.6% reported in the prior year period.
Net Income Increased 14% Net income $392.6M, reflecting 14% increase compared to $344.6M reported in the prior year period.
Strong Liquidity Position Cash and equivalents total $1.42B; $1.5B available on revolving credit facility as of period end.

Risk Factors

Restructuring Charges Taken Recorded $5.9M restructuring charges for workforce planning activities impacting both operating segments this quarter.
Tax Rate Increase Impact Effective tax rate rose to 20.9% due to Pillar Two global minimum tax implementation across global mix.
Pending Litigation Exposure Involved in multiple patent infringement suits; final outcomes are uncertain, potential material adjustment possible.
Intangible Amortization Rises Amortization of acquired intangibles rose to $11.8M for the quarter due to VirtuOx acquisition intangibles.

Outlook

R&D Investment Focus Invested $91.0M in R&D, emphasizing new features for AirSense 11 device platform and product pipeline.
Treasury Stock Activity Deployed $325.0M for treasury stock purchases during the first six months ended December 31, 2025 period.
Debt Facility Maintained Maintained $1.5B available under revolving credit facility, ensuring strong liquidity for future operational needs.
Future Tax Guidance Monitoring Monitoring OECD Pillar Two guidance, specifically the Side-by-Side Safe Harbor expected to impact fiscal year 2027.

Peer Comparison

Revenue (TTM)

CAH stock ticker logoCAH
$244.49B
+10.1%
HUM stock ticker logoHUM
$129.66B
+10.1%
TAK stock ticker logoTAK
$30.01B
-2.0%

Gross Margin (Latest Quarter)

INSM stock ticker logoINSM
82.5%
-18.6pp
EW stock ticker logoEW
78.3%
-2.7pp
HLN stock ticker logoHLN
65.0%
+0.7pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
BDX$59.37B26.66.9%35.6%
TAK$57.53B80.81.6%31.5%
CAH$51.07B30.7-58.9%15.5%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
3.3%
Moderate Growth
4Q Net Income CAGR
2.5%
Profitability Slowly Improving
Cash Flow Stability
100%
Strong Cash Flow

Deep Research

Next earnings:Apr 21, 2026
|
EPS:-
|
Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data